The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
Introduction: Vision impairment caused by retinal diseases stands out as one of the significant sources of irreversible blindness, highlighting the importance of developing robust automated screening tools to detect eye diseases at an early stage. Despite the promising results of recent deep learning approaches to the automatic classification of retinal images, most existing solutions focus on image-based representations and do not consider the importance of vascular topology. To overcome the limitations, this study proposes VG-RETFound - a hybrid framework based on a retinal foundation model and graph-based vascular-topology modeling that can be used to classify multiple retinal categories and detect vision impairment. Methods: The authors use RETFound-a retinal foundation model-pretrained on a vast number of retinal images, as well as the Graph Attention Network (GAT), to learn vascular topology features by representing retinal vessels as graphs. The presented approach employs a cross-modal multi-head attention fusion method to integrate features from both modalities in real time. To evaluate the efficiency of VG-RETFound, experiments were conducted using the RFMiD and ODIR-5 K datasets for model training and testing across six retinal categories: Normal, Diabetic Retinopathy, Pathological Myopia, Age-related Macular Degeneration, Hypertensive Retinopathy, and Other Retinal Diseases. Results: The accuracy of 96.39%, F1-score of 95.84%, MCC of 94.87%, and Kappa of 94.71% were attained on an internal test dataset, while cross-dataset external validation on the BRSET dataset revealed accuracy of 94.81%, F1-score of 94.25%, MCC of 93.09%, and Kappa of 92.94%. Discussion: These findings demonstrate that integrating retinal foundation models with anatomically informed vessel-topology learning significantly improves classification accuracy, interpretability, and generalization, highlighting the potential of VG-RETFound as a tool for large-scale vision impairment. screening and retinal disease diagnosis.
Ubiquitin machinery is an essential regulatory system that maintains protein stability, degradation, and signalling by balancing ubiquitination and deubiquitination. In addition to its classical function in protein tagging for proteasomal degradation, ubiquitin has several essential cellular functions, including cell-cycle regulation, DNA repair, immunomodulation, intracellular signalling, and cellular stress responses. Abnormal regulation of this highly ordered system has been implicated in the pathogenesis of cancer, neurodegenerative diseases, infectious diseases, metabolic dysfunction, and autoimmunity. Recent developments in structural biology, chemical biology, and proteomics have increased our understanding of ubiquitin signalling and identified new therapeutic targets by revealing context-specific interactions within nodes of the ubiquitinproteasome system. Future approaches to restore proteostasis involve selective inactivation of proteasomal subunits, E3 ligases, and deubiquitinating enzymes (DUBs), as well as novel modalities such as proteolysistargeting chimeras (PROTACs) and molecular glues that redirect ubiquitin-dependent degradation of diseaserelevant proteins. Although preclinical and early clinical studies have demonstrated target specificity, longterm safety remains a challenge for clinical translation. This review provides an overview of ubiquitin's pathophysiological functions in key human diseases, therapeutic interventions, and the potential of ubiquitin-based therapeutic strategies for precision medicine and targeted drug therapy.
Frontiers in Veterinary Science · vol. 12 · 1558954-1558954
Introduction Our investigations utilized computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography (US) to provide detailed anatomical information on the pes region of a one-humped camel, with a particular focus on 3D reconstruction volume-rendered CT (3DVR-CT). Methods This research utilized 16 pes regions from adult male Camelus dromedaries aged 8–10 years. Results A CT scan revealed a vertical bony septum that completely divides the internal medullary cavity of the fused large metatarsal bones along the fusion line, except for the distal one-fifth portion, where the septum was absent. MRI identified the ligaments of the fetlock joint, which include the axial and abaxial collateral ligaments, collateral sesamoidean ligaments, and palmar ligaments. US demonstrated that the deep digital flexor tendon (DDFT) had higher echogenicity than the superficial digital flexor tendon (SDFT) at all imaging levels, with the SDFT paratendon appearing hyperechoic, which differentiated it from both the SDFT and the suspensory ligament. Our application of CT and MRI imaging techniques revealed that the Manica flexoria and distal sesamoid bone were not observed. On MRI, the sole appeared as a layer of low signal intensity, while the digital cushion exhibited heterogeneous high signal intensity. Discussion the evaluation of anatomical regions in Camelus dromedaries can now be performed using CT, MRI, and US with 3DVR-CT, greatly improving the diagnosis and treatment of various conditions and facilitating the interpretation of some clinical diseases in the pes region. These imaging modalities, particularly 3DVR-CT, serve as valuable tools for veterinary clinicians and researchers studying camel anatomy and pathology.
Camelus dromedariusfoot anatomymetatarsalsdeep digital flexor tendon
BACKGROUND: The World Health Organization defines health as complete physical, mental, and social well-being. Chronic diseases impact health-related quality of life (QoL). Health services for ill populations, including end-stage renal disease (ESRD), focus on QoL issues and mental health promotion. Kidney transplantation is the optimal form, but most patients require dialysis, which can be hemodialysis (HD) or peritoneal dialysis (PD). It is believed that choosing the proper modality will help in improving patient's QoL and satisfaction rate. To help patients select the mode of dialysis that best meets their needs while they have ESRD, this study intends to investigate differences in QoL between dialysis modalities. METHODOLOGY: It was a multicenter cross-sectional study conducted in Saudi Arabia, focusing on HD and PD patients in specific hospitals. Data was collected through a specially designed online questionnaire and analyzed with IBM SPSS 29 (IBM Corp. Released 2023. IBM SPSS Statistics for Windows, Version 29.0.2.0 Armonk, NY: IBM Corp). RESULTS: Our study, including 307 dialysis patients in Saudi Arabia, revealed a male predominance (56.0%), primarily aged 45-64 years (43.0%), with 91.5% Saudi nationals. Employment varied (27.4% professionals), and most earned 10,000-20,000 SAR monthly (50.5%). Positive life changes post-dialysis were reported by 98.7%, with 94.5% not requiring post-dialysis absence from work. Incenter HD patients constitute 45.3% while PD patients constitute 54.7% of the study sample. Physical well-being showed significant differences in nausea (p=0.035). Social and emotional well-being exhibited acceptance variations (p=0.012) and coping satisfaction (p=0.014). Linear regression indicated monthly income impact on HD QoL (B=-3.706, p=0.075), while age influenced PD QoL (B=0.113, p=0.927). CONCLUSION: Our study underscores positive life changes and minimal work absence is prevalent among dialysis patients. PD exhibits higher nausea and lower family acceptance. HD participants report greater coping satisfaction. The study reveals nuanced differences in well-being dimensions, contributing insights for tailored interventions and patient-centered care in renal replacement therapies.
health-related quality of lifeperitoneal dialysishemodialysisend-stage renal disease
Brain Research Bulletin · vol. 233 · 111645-111645
Epilepsy is a critical neurological disorder that requires accurate and privacy-preserving diagnostic solutions to enable early detection and effective management. However, existing approaches face key challenges, including reliance on centralized data, poor generalizability across modalities, suboptimal feature extraction, and vulnerability to noise. To address these issues, we propose MultiEpilepsyNet, a novel multimodal seizure detection framework that integrates federated learning with hybrid deep learning models. At its core, the system introduces SeizureFed-Net, a federated architecture that enables collaborative learning from EEG and MRI data while safeguarding patient privacy. For detection, we design SeizureShieldNet, a hybrid model that fuses the temporal learning capabilities of BBIDNet (Boosted BiLSTM Intrusion Detector Network) with the adaptive decision-making of FD-TMS (Fuzzy-DQN Threat Mitigation System) under uncertainty. To further enhance model efficiency, a Jackal-Wolf Hybrid Optimizer (JWHO)-a novel combination of Golden Jackal Optimization and Grey Wolf Optimizer-is employed for optimal feature subset selection. On the imaging side, MRI preprocessing is improved through EpiSkullNet+ +, a modified 3D UNet+ + architecture tailored for precise brain segmentation. Extensive experiments on two benchmark datasets demonstrate the superiority of our approach, achieving 99.36 % accuracy on the CHB-MIT EEG dataset and 99.38 % accuracy on an epilepsy MRI dataset. Beyond accuracy, MultiEpilepsyNet demonstrates improved robustness to missing modalities, reduced training overhead via federated aggregation, and enhanced privacy preservation compared to centralized deep learning models, thereby addressing critical barriers in practical clinical deployment. These outcomes highlight the effectiveness, scalability, and real-world clinical potential of the proposed framework for epilepsy diagnosis and management.
Current Medical Imaging Formerly Current Medical Imaging Reviews · vol. 21 · e15734056391923-e15734056391923
INTRODUCTION: Accurate interpretation of medical images is vital for diagnosis and treatment planning. However, noise in medical imaging significantly hampers this process, leading to potential diagnostic errors. Traditional denoising techniques often require large datasets or compromise diagnostic details. METHOD: This study proposes a Distribution-based Compressed Denoising Scheme (DCDS) leveraging transfer learning to enhance diagnostic precision. The framework analyzes pixel distributions to distinguish normal and noisy pixels using incremental and decremental distribution verification. A chest CT scan dataset with Gaussian-like noise was used to train the model, employing correlation mapping between training and target images for effective variance estimation. RESULT: Experimental analysis showed that DCDS significantly improves noise reduction, variance detection, and diagnostic precision. The peak signal-tonoise ratio improved across all evaluated ranges (24-32 dB), with a noise reduction rate exceeding 82% in optimal conditions. DCDS reduced mean error and analysis time, enhancing overall system efficiency. Transfer learning allowed for effective pixel classification and noise prediction with fewer data and computational resources. DISCUSSION: Compared to existing denoising methods, DCDS offers better generalization through statistical modeling and knowledge-sharing between training and learning states. However, current validation is limited to CT imaging with Gaussian noise. Broader modality testing and integration of perceptual and clinical grading metrics are needed. CONCLUSION: The DCDS framework presents a promising, lightweight, adaptive, and accurate solution for medical image denoising. It holds potential for realtime diagnostic support, but further optimization and clinical validation are necessary to ensure generalizability across diverse imaging modalities and noise types.
medical image denoisingtransfer learningchest CTGaussian noise
Journal of Advanced Trends in Medical Research · vol. 2 (4) · 671-681
Hair loss, or alopecia, encompasses a diverse range of conditions including both cicatricial (scarring) and non-cicatricial (non-scarring) forms, with significant implications for patients’ physical appearance, psychological well-being and overall quality of life. The limitations of traditional therapies such as topical agents, oral medications and hair transplantation have led to increasing interest in regenerative approaches. Amongst these, platelet-rich plasma (PRP) and exosome-based therapies have emerged as promising biologic interventions. PRP, derived from autologous blood, contains a high concentration of platelets rich in growth factors that support hair follicle regeneration, angiogenesis and cellular proliferation. Evidence suggests its potential benefits in various types of hair loss particularly androgenetic alopecia, alopecia areata and telogen effluvium, although standardised protocols, optimal dosing and long-term outcomes remain uncertain. Exosomes are small extracellular vesicles secreted by stem cells that offer a novel cell-free alternative capable of delivering complex molecular signals to modulate inflammation, stimulate follicular stem cells, and promote dermal remodeling. Early findings indicate possible applications across a range of alopecias including chemotherapy-induced hair loss, autoimmune related alopecia and structural hair shaft disorders such as trichorrhexis nodosa and monilethrix. This narrative review provides an updated overview of PRP and exosome-based therapies, outlining their mechanisms of action, clinical applications and current limitations. While both modalities show therapeutic promise, their biologic variability, lack of regulatory standardisation and need for comparative trials highlight critical gaps in evidence. Further research is warranted to establish reproducible treatment protocols and determine long-term efficacy and safety for clinical use.
International Journal of Imaging Systems and Technology · vol. 35 (5)
ABSTRACT Recent advancements in Deep Learning (DL) have enabled the development of Computer‐Aided Diagnosis (CAD) systems for detecting Acute Lymphoblastic Leukemia (ALL) and its subtypes. However, this field faces challenges, particularly due to limited annotated datasets and a lack of efficient modalities. To address these issues, we propose MHAOSL‐net, a novel hybrid DL model specifically designed for the accurate classification of B‐ALL, T‐ALL, and normal cells in blood smear images. The key contributions lie in the integration of four primary components: (1) lightweight MobileNetV2 for backbone feature extraction, (2) a Global Context Information Convolutional Block Attention Module (GCI‐CBAM) for refined local representation using contextual information, (3) an Attention‐Free Transformer (AFT) that captures global dependencies replacing traditional self‐attention, and (4) an Orthogonal SoftMax Layer (OSL) that improves class separability by enforcing orthogonality in the decision space. This unified architecture not only reduces computational overhead but also improves classification performance and generalizability. To the best of our knowledge, this is the first framework that combines an AFT with an OSL in the context of leukemia subtype detection. The performance analysis of the proposed 3‐class classification scheme has been assessed on two novel datasets, namely BBCI_B&T_ALL_2024 and heterogeneous datasets. The experimental results show that the proposed scheme provides better performance, with 99.52% accuracy, 99.36% average precision, and 99.36% average F1‐score on the BBCI_B&T_ALL_2024. Similarly, it achieves better performance with 99.55% accuracy, 99.40% average precision, and 99.40% average F1‐score on the heterogeneous dataset. The qualitative investigation using Gradient‐weighted Class Activation Mapping (Grad‐CAM) visualization also confirms the efficacy of the proposed model for detecting B‐ALL, T‐ALL, and normal cells. The comparative studies establish the superiority of the proposed scheme over other state‐of‐the‐art approaches. These findings indicate that MHAOSL‐Net offers a promising and efficient solution for reliable ALL subtype detection in clinical settings.
Advanced Health Science and Technology Journal · vol. 1 (2) · 92-99
Abstract Background: Epilepsy remains one of the most prevalent neurological disorders worldwide, characterized by recurrent seizures resulting from abnormal electrical brain activity. Traditional diagnostic methods, such as electroencephalography (EEG) and magnetic resonance imaging (MRI), although widely used, often fail to provide sufficient accuracy when applied in isolation due to their inherent limitations in temporal or spatial resolution. These challenges highlight the need for integrated analytical approaches capable of leveraging complementary modalities for improved diagnostic precision. Objectives: This study aims to address the limitations of single-modality diagnostic techniques by proposing a multimodal deep learning framework that integrates EEG and MRI data to enhance the accuracy of epilepsy detection. The objectives include preprocessing EEG signals to remove artifacts, segmenting MRI scans for structural feature extraction, employing CNNs to model EEG spatio-temporal dependencies, using ViTs to capture hierarchical MRI features, and integrating these representations through a cross-attention fusion mechanism for effective supervised classification. Method: The methodology involves preprocessing EEG signals to eliminate artifacts and ensure clean temporal representation, along with MRI scan segmentation to extract structural information. Convolutional neural networks (CNNs) were used to model spatio-temporal patterns within EEG signals, while vision transformers (ViTs) extracted spatially hierarchical features from MRI data. A cross-attention fusion mechanism was designed to integrate these complementary modalities, and a supervised classifier performed the final prediction. Model training and evaluation were carried out using a high-performance computing setup with GPU acceleration to efficiently handle multimodal data. Results: Experimental results demonstrated that the proposed multimodal deep learning model significantly outperformed state-of-the-art pretrained CNN and ViT baselines across major evaluation metrics, including accuracy, precision, recall, F1-score, and Matthews correlation coefficient. The confusion matrix further confirmed robust differentiation between normal and epileptic classes, emphasizing the reliability of the proposed framework for accurate clinical decision-making. Conclusion: The findings of this study indicate that integrating EEG and MRI data through a multimodal fusion framework provides a substantial improvement in epilepsy detection compared to single-modality approaches. The results highlight the importance of combining complementary temporal and structural information to achieve reliable diagnostic performance. This work contributes to advancing early detection, reducing diagnostic errors, and supporting timely treatment strategies, reinforcing the value of multimodal deep learning approaches in personalized healthcare.
Fox-Fordyce disease (FFD) is a rare, chronic skin disorder affecting apocrine sweat glands, predominantly in women. It manifests as pruritic, dome-shaped papules in areas such as the axillae and pubic region. Treatment remains challenging, with limited success from conventional therapies. We report two cases of Saudi women aged 27 and 28 years presenting with hyperpigmented axillary papules and mild pruritus, consistent with FFD. One patient had no comorbidities, while the other had a known history of sickle cell anemia. Both cases were managed with laser therapy (erbium:yttrium aluminum garnet (YAG) in case 1 and ablative CO₂ in case 2) using precise protocols and follow-up plans. Clinical images demonstrated visual improvement post treatment. Adjunctive topical therapy was administered to manage inflammation and prevent hyperpigmentation. The cases underscore the typical presentation of FFD and the potential efficacy of laser-based interventions, even in patients with complex medical histories. Notably, the presence of sickle cell anemia did not exacerbate FFD manifestations, supporting the current treatment modalities. While hormonal therapy was not employed, its relevance remains a subject for future exploration. Laser therapy offers a promising approach for managing refractory FFD. Further studies are warranted to evaluate long-term outcomes and explore hormone-modulating strategies tailored to FFD's pathophysiology.
Oral squamous cell carcinoma (OSCC) is a highly malignant and invasive tumor with significant mortality and morbidity. Current treatment modalities such as surgery, radiotherapy, and chemotherapy encounter significant limitations, such as poor targeting, systemic toxicity, and drug resistance. There is an urgent need for novel therapeutic strategies that offer targeted delivery, enhanced efficacy, and reduced side effects. The advent of lipid-based nanoparticles (LNPs) offers a promising tool for OSCC therapy, potentially overcoming the limitations of current therapeutic approaches. LNPs are composed of biodegradable and biocompatible lipids, which minimize the risk of toxicity and adverse effects. LNPs can encapsulate hydrophobic drugs, improving their solubility and stability in the biological environment, thereby enhancing their bioavailability. LNPs demonstrate significantly higher ability to encapsulate lipophilic drugs than other nanoparticle types. LNPs offer excellent storage stability, minimal drug leakage, and controlled drug release, making them highly effective nanoplatforms for the delivery of chemotherapeutic agents. Additionally, LNPs can be modified by complexing them with specific target ligands on their surface. This surface modification allows the active targeting of LNPs to the tumors in addition to the passive targeting mechanism. Furthermore, the PEGylation of LNPs improves their hydrophilicity and enhances their biological half-life by reducing clearance by the reticuloendothelial system. This review aims to discuss current treatment approaches and their limitations, as well as recent advancements in LNPs for better management of OSCC.
oral squamous cell carcinomalipid nanoparticlestargeted drug deliverychemotherapy
Clinical Case Reports · vol. 12 (11) · e9378-e9378
Key Clinical Message: It is important to consider the diagnosis of Sump syndrome in patients with a history of open cholecystectomy, particularly in those who migrate from developing countries where alternative biliary interventions may be limited. The presentation may range from acute severe, mimicking acute ascending cholangitis, to chronic recurrent abdominal pain without evidence of inflammation. Management is a case-by-case decision, with principal management aims to decompress the biliary tract and address any underlying sepsis. Abstract: Sump syndrome is a rare and often long-term complication of choledochoduodenostomy (CDD). The presentation and severity are variable, and management should be tailored to each patient based on several factors. Herein, we report three cases of sump syndrome, each demonstrating unique diagnostic dilemmas and therapeutic modalities. Case I describes a woman presenting with acute cholangitis, managed with percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP). Case II illustrates a similar presentation complicated by myocardial infarction, necessitating urgent biliary decompression via PTC and subsequent unsuccessful endoscopic stenting. Case III highlights the diagnostic difficulty in a stable patient with inconclusive diagnostic imaging. This case series emphasizes the importance of considering sump syndrome diagnosis in patients with a history of CDD or open cholecystectomy, especially in elderly patients and those who come from regions where alternative biliary interventions may be limited.
In vascular neurosurgery, dural arteriovenous fistulas (DAVFs) are a difficult, challenging condition whose natural history and therapy are still debated. This case report presented a 30-year-old male patient who experienced intermittent headaches for two months, along with gradual weakness in all four limbs, resulting in quadriplegia. Magnetic resonance imaging (MRI), computed tomography (CT), and digital subtraction angiography (DSA) played a significant role in the diagnosis of the patient, in which the final diagnosis was vascular myelopathy due to Dural arteriovenous fistula (DAVF). A successful embolization procedure of arteriovenous fistula using balloon-assisted liquid embolic agents, through branches of the right occipital artery was performed, resulting in complete obliteration of the fistula. In order to improve the neurovascular symptoms that had previously been reported, the patient was effectively undergoing rehabilitation, with notable progress.
Journal of Advanced Trends in Medical Research · vol. 1 (3) · 784-790
Abstract Background: Traumatic brain injury (TBI) in children is still a major concern amongst healthcare worldwide as it causes raised morbidity and mortality rate. Identification of TBI cases is therefore paramount in treatment with diagnostic imaging techniques such as the computed tomography (CT) and magnetic resonance imaging (MRI) amongst others. However, deciding between the two methods has been a challenge since radiation exposure by CT and the limitation of MRI, which include longer time for scan and most importantly, need for use of sedation amongst children. This review aims at analysing and comparing accuracy of CT and MRI in diagnosing paediatric TBI; the effects of the two MRI scans on prognosis and the contribution of the two scans in management decision-making. Furthermore, the views on safety issues connected with radiation in CT as well as whether the modern MRI methods can improve the diagnostic potential without safety issues are also discussed. Methods: A literature search using the PubMed, Scopus and Google Scholar databases was done with terms such as ‘point of care’, ‘clinical decision support’, ‘decision support system’ was used with an emphasis on articles published in the past 15 years. Article titles used were ‘paediatric traumatic brain injury’, ‘CT in paediatric TBI’, ‘MRI in paediatric TBI’ and ‘diagnostic accuracy of imaging in TBI’. The review of articles involved only patients aged between 0 and 18 years diagnosed with TBI through CT or MRI that provided data on diagnostic accuracy, clinical management and safety considerations. Results: CT is used in the management of acute TBI because it is fast and widely available, especially for instance in emergency situations. MRI, however, has the advantages of producing higher sensitivity in identification of diffuse axonal injuries and less evident pathologies of the brain that may not be identified in a CT. However, MRI has limitations such as long time to perform a scan, is expensive and requires administration of sedatives to children making it less suitable for use in the acute care settings. Third, despite its effectiveness, CT exposes the patient to radiation that increases his/her chances of getting cancer especial if the patient is a child. Newer techniques in MRI have emerged which enhance the capacity of diagnosis of paediatric TBI and its further management and prognosis; these are the diffusion tensor imaging and susceptibility-weighted imaging. Conclusions: CT and MRI should both be used in the evaluation of paediatric TBI because they each provide information that the other cannot. CT scan has remained the primary imaging modality in the acute setting because of the speed in availability and to assess the critical lesions, whereas MRI offers a detailed examination of TBI important in the post-acute phase. This review is helpful in establishing possible guidelines that will help in the use of these imaging techniques in paediatric TBI that will enhance the detection of the injury without exposing the patients to additional harm. More investigation is, therefore, required to standardise the techniques and protocols that improve the efficiency of imaging procedures for therapeutic processes, while avoiding adverse effects such as radiation hazards.
Frontiers in Neuroanatomy · vol. 17 · 1090738-1090738
Background: The majority of the suggested experimental modalities for peripheral nerve injury (PNI) result in varying degrees of recovery in animal models; however, there are not many reliable clinical pharmacological treatment models available. To alleviate PNI complications, research on approaches to accelerate peripheral nerve regeneration is encouraged. Cerebrolysin, dexamethasone, and ascorbic acid (vitamin C) drug models were selected in our study because of their reported curative effects of different mechanisms of action. Methodology: = 8). The sciatic nerve sensory and motor function regeneration after crushing together with gastrocnemius muscle histopathological changes were evaluated by the sciatic function index, the hot plate test, gastrocnemius muscle mass ratio, and immune expression of S100 and apoptosis cascade (BAX, BCL2, and BAX/BCL2 ratio). Results: Significant improvement of the behavioral status and histopathological assessment scores occurred after the use of Cerebrolysin (as a neurotrophic factor), dexamethasone (as an anti-inflammatory), and vitamin C (as an antioxidant). Despite these seemingly concomitant, robust behavioral and pathological changes, vitamin C appeared to have the best results among the three main outcome measures. There was a positive correlation between motor and sensory improvement and also between behavioral and histopathological changes, boosting the effectiveness, and implication of the sciatic function index as a mirror for changes occurring on the tissue level. Conclusion: Vitamin C is a promising therapeutic in the treatment of PNI. The sciatic function index (SFI) test is a reliable accurate method for assessing sciatic nerve integrity after both partial disruption and regrowth.